Daiichi Sankyo Group Policy on Access to Healthcare
The Daiichi Sankyo Group works to address access to healthcare across its entire value chain, which spans everything from research and development to manufacturing, sales & marketing, and quality & safety management, and prioritizes the following three areas: Research and Development, Availability, and Capacity Building.
Through these initiatives, we contribute to the Sustainable Development Goals (SDGs) established by the United Nations, "Goal 3: Ensure healthy lives and promote well-being for all at all ages."
At the same time, we are promoting initiatives for “Goal 9: Industry, Innovation and Infrastructure” and “Goal 17: Partnerships for the Goals.”
The Group will contribute to ensuring healthy lives and promoting well-being for all by working to resolve unmet medical needs, such as cancer and other non communicable diseases, rare diseases, malaria, tuberculosis, and neglected tropical diseases.